CSI Market
Sign In | Register

Aspire Biopharma Holdings Inc (ASBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ASBP Annual Balance Sheets →
Quarterly balance sheet trends provide context on Aspire Biopharma Holdings Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent12.17
Cash & Short-term Investments12.00
Inventories0.29
Prepaid Expense And Other Assets Current1.01
Total Current Assets13.47
Deferred, Prepaid and Other Assets, Noncurrent0.08
Other Assets, Noncurrent0.00
Total Assets13.54
Liabilities
Accounts Payable, Current AC0.97
Accrued Liabilities, Current AC0.71
Derivative Liability, Current DE0.00
Loans Payable, Current NO0.00
Other Liabilities, Current0.00
Total Current Liabilities1.69
Total Long-term Debt0.00
Other liabilities, Noncurrent0.10
ForwardPurchaseAgreementLiability0.10
Promissory Note Fee1.00
Total Liabilities1.78
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock43.51
Retained Earnings / Accumulated Deficit-31.75
Other Equity0.00
Common Stockholder's Equity11.76
Total Stockholder's Equity11.76
Liabilities & Stockholder's Equity13.54
4 historic quarters locked

Sign in to unlock the full Aspire Biopharma Holdings Inc balance sheet history.

Sign In Create Free Account

About Aspire Biopharma Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037819

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.